

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.34847082 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.34847082 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.34847082 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.34847082 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.34847082 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.34847082 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.78005155 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.43998922 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.43085377 |
| 10 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.17016212 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.98930449 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.79343221 |
| 13 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.74123832 |
| 14 | response to peptidoglycan (GO:0032494) | 4.59602134 |
| 15 | positive regulation of interferon-alpha production (GO:0032727) | 4.57461267 |
| 16 | regulation of chronic inflammatory response (GO:0002676) | 4.50455608 |
| 17 | regulation of interferon-alpha production (GO:0032647) | 4.40672224 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37761508 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.37761508 |
| 20 | T cell migration (GO:0072678) | 4.25405522 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.25121999 |
| 22 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.22299462 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.11331836 |
| 24 | response to host immune response (GO:0052572) | 4.07974635 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.07974635 |
| 26 | respiratory burst (GO:0045730) | 4.07879539 |
| 27 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.99456093 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.94767220 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90579917 |
| 30 | natural killer cell mediated immunity (GO:0002228) | 3.87559936 |
| 31 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.87559936 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.78759507 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.77902870 |
| 34 | T cell lineage commitment (GO:0002360) | 3.77570980 |
| 35 | granulocyte activation (GO:0036230) | 3.76121998 |
| 36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.74981869 |
| 37 | myeloid cell activation involved in immune response (GO:0002275) | 3.70899502 |
| 38 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.70455192 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.69682677 |
| 40 | neutrophil activation (GO:0042119) | 3.69329401 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.68799108 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 3.68683621 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.68182589 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.67871489 |
| 45 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.67552621 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65345104 |
| 47 | response to host (GO:0075136) | 3.65345104 |
| 48 | response to host defenses (GO:0052200) | 3.65345104 |
| 49 | positive regulation of defense response to virus by host (GO:0002230) | 3.64319462 |
| 50 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.60777349 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.60760163 |
| 52 | positive regulation of interferon-beta production (GO:0032728) | 3.57761731 |
| 53 | regulation of T-helper cell differentiation (GO:0045622) | 3.57180847 |
| 54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.56638458 |
| 55 | type I interferon signaling pathway (GO:0060337) | 3.56358712 |
| 56 | cellular response to type I interferon (GO:0071357) | 3.56358712 |
| 57 | response to type I interferon (GO:0034340) | 3.56309557 |
| 58 | cellular response to interferon-gamma (GO:0071346) | 3.55532009 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.54043178 |
| 60 | cytidine metabolic process (GO:0046087) | 3.53716275 |
| 61 | cytidine catabolic process (GO:0006216) | 3.53716275 |
| 62 | cytidine deamination (GO:0009972) | 3.53716275 |
| 63 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.52541814 |
| 64 | negative regulation of cell killing (GO:0031342) | 3.50861319 |
| 65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.50861319 |
| 66 | defense response to protozoan (GO:0042832) | 3.48089091 |
| 67 | positive regulation of B cell mediated immunity (GO:0002714) | 3.47767719 |
| 68 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.47767719 |
| 69 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42506534 |
| 70 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.42325657 |
| 71 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.41785960 |
| 72 | regulation of interleukin-12 production (GO:0032655) | 3.40820924 |
| 73 | I-kappaB phosphorylation (GO:0007252) | 3.40105183 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.38862685 |
| 75 | macrophage activation (GO:0042116) | 3.37567227 |
| 76 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36448142 |
| 77 | regulation of B cell proliferation (GO:0030888) | 3.35449087 |
| 78 | positive regulation of humoral immune response (GO:0002922) | 3.33819835 |
| 79 | microglial cell activation (GO:0001774) | 3.33026712 |
| 80 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.32558906 |
| 81 | positive regulation of B cell proliferation (GO:0030890) | 3.31191945 |
| 82 | positive regulation of type 2 immune response (GO:0002830) | 3.30027771 |
| 83 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.28308103 |
| 84 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.25670827 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.24833077 |
| 86 | lymphocyte costimulation (GO:0031294) | 3.24182890 |
| 87 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.23480003 |
| 88 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23173417 |
| 89 | negative regulation of B cell proliferation (GO:0030889) | 3.22467063 |
| 90 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.22316314 |
| 91 | T cell costimulation (GO:0031295) | 3.21902719 |
| 92 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.21220354 |
| 93 | negative regulation of interleukin-12 production (GO:0032695) | 3.19560550 |
| 94 | response to interferon-gamma (GO:0034341) | 3.19203175 |
| 95 | positive regulation of interleukin-10 production (GO:0032733) | 3.18936718 |
| 96 | B cell mediated immunity (GO:0019724) | 3.18204261 |
| 97 | regulation of chemokine biosynthetic process (GO:0045073) | 3.17319228 |
| 98 | positive regulation of heat generation (GO:0031652) | 3.14388043 |
| 99 | positive regulation of interleukin-2 production (GO:0032743) | 3.14350532 |
| 100 | B cell proliferation (GO:0042100) | 3.13187548 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.13149890 |
| 102 | regulation of B cell differentiation (GO:0045577) | 3.12422094 |
| 103 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.11962321 |
| 104 | response to protozoan (GO:0001562) | 3.11553791 |
| 105 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11165066 |
| 106 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.10697106 |
| 107 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.09853615 |
| 108 | negative T cell selection (GO:0043383) | 3.09268619 |
| 109 | dendritic cell differentiation (GO:0097028) | 3.07495347 |
| 110 | superoxide anion generation (GO:0042554) | 3.07032597 |
| 111 | regulation of immunoglobulin secretion (GO:0051023) | 3.06782587 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 3.05788484 |
| 113 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.05530228 |
| 114 | detection of molecule of bacterial origin (GO:0032490) | 3.04467377 |
| 115 | negative thymic T cell selection (GO:0045060) | 3.02327695 |
| 116 | response to interferon-alpha (GO:0035455) | 3.01971706 |
| 117 | interferon-gamma production (GO:0032609) | 2.99522056 |
| 118 | positive regulation of B cell activation (GO:0050871) | 2.99514836 |
| 119 | leukocyte aggregation (GO:0070486) | 2.99495407 |
| 120 | regulation of antigen processing and presentation (GO:0002577) | 2.99085985 |
| 121 | cellular response to zinc ion (GO:0071294) | 2.98933488 |
| 122 | negative regulation of interleukin-17 production (GO:0032700) | 2.98552272 |
| 123 | reactive oxygen species biosynthetic process (GO:1903409) | 2.98412220 |
| 124 | regulation of hypersensitivity (GO:0002883) | 2.97461578 |
| 125 | B cell homeostasis (GO:0001782) | 2.97130559 |
| 126 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.97102519 |
| 127 | germinal center formation (GO:0002467) | 2.96445337 |
| 128 | DNA deamination (GO:0045006) | 2.95658715 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.94375115 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.94353358 |
| 131 | pinocytosis (GO:0006907) | 2.93974722 |
| 132 | myeloid dendritic cell differentiation (GO:0043011) | 2.90955059 |
| 133 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.90734812 |
| 134 | myeloid leukocyte activation (GO:0002274) | 2.89759270 |
| 135 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.89126705 |
| 136 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89040338 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87458107 |
| 138 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.87453592 |
| 139 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84878455 |
| 140 | mature B cell differentiation (GO:0002335) | 2.84753057 |
| 141 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84737745 |
| 142 | regulation of mast cell activation (GO:0033003) | 2.79459114 |
| 143 | neutrophil mediated immunity (GO:0002446) | 2.78806276 |
| 144 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77073193 |
| 145 | leukocyte cell-cell adhesion (GO:0007159) | 2.75579093 |
| 146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74172176 |
| 147 | positive regulation of interleukin-12 production (GO:0032735) | 2.74029826 |
| 148 | negative regulation of viral genome replication (GO:0045071) | 2.73252106 |
| 149 | regulation of fever generation (GO:0031620) | 2.73008399 |
| 150 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.72924429 |
| 151 | regulation of interferon-beta production (GO:0032648) | 2.72289682 |
| 152 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.70059028 |
| 153 | positive regulation of mast cell activation (GO:0033005) | 2.69744227 |
| 154 | leukocyte mediated cytotoxicity (GO:0001909) | 2.69140998 |
| 155 | lymphocyte mediated immunity (GO:0002449) | 2.69121801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.56100320 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.16624689 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.64117639 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.18406711 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.04555008 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.94635403 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.82559886 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63955322 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.63375332 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.50907742 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.50510235 |
| 12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.26636022 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02034014 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01228883 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78643375 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75772180 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.64282416 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.60627183 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.35681911 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29377533 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24514246 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22980965 |
| 23 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11312181 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03171907 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.98815297 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97803673 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94563615 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92762427 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92372133 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.92081523 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.90990300 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.89992277 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.87403385 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87084825 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.85027581 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83537443 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82411787 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.81544588 |
| 39 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.79239221 |
| 40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73565191 |
| 41 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66145231 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61952414 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58320947 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56779766 |
| 45 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53958925 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53949142 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.51962744 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51351368 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48879978 |
| 50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48570654 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47366572 |
| 52 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.45729373 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43548157 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38082150 |
| 55 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.36587843 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.36309980 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36089520 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35441154 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34308097 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31474666 |
| 61 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29946134 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28207712 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27554965 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27043760 |
| 65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25794137 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25481555 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23910076 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21557048 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20242409 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17795219 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17684323 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16843732 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12990852 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11423833 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.10953590 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.08894512 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07435461 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06982988 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05295680 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05259906 |
| 81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05080445 |
| 82 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01419214 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01221713 |
| 84 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98872254 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95866140 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94974850 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93789118 |
| 88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.93090281 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92578418 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91940008 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91329058 |
| 92 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90147182 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90046444 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89645731 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89515720 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87672758 |
| 97 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.87399347 |
| 98 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86179339 |
| 99 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82212394 |
| 100 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81586553 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81586553 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81255613 |
| 103 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.80368034 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78613305 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78360466 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78263154 |
| 107 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78113421 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76576273 |
| 109 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.74934890 |
| 110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74079143 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72094654 |
| 112 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.71632208 |
| 113 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70961710 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.68004228 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.67950694 |
| 116 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.67764659 |
| 117 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.67444254 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67284691 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66706143 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66202678 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66111534 |
| 122 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.65562235 |
| 123 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.65317009 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65070560 |
| 125 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.65011272 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.63252570 |
| 127 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63240969 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63196297 |
| 129 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.63039399 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62621821 |
| 131 | P300_27268052_Chip-Seq_Bcells_Human | 0.62424605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.41867231 |
| 2 | MP0003303_peritoneal_inflammation | 3.45671838 |
| 3 | MP0003436_decreased_susceptibility_to | 3.43795271 |
| 4 | MP0009785_altered_susceptibility_to | 3.34625282 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.05418139 |
| 6 | MP0002419_abnormal_innate_immunity | 3.04888950 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.89135718 |
| 8 | MP0001790_abnormal_immune_system | 2.88990371 |
| 9 | MP0005387_immune_system_phenotype | 2.88990371 |
| 10 | MP0005025_abnormal_response_to | 2.83837974 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.82641962 |
| 12 | MP0001800_abnormal_humoral_immune | 2.80705753 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.75220486 |
| 14 | MP0005671_abnormal_response_to | 2.72134248 |
| 15 | MP0000685_abnormal_immune_system | 2.63114672 |
| 16 | MP0002723_abnormal_immune_serum | 2.59961633 |
| 17 | MP0006082_CNS_inflammation | 2.58109391 |
| 18 | MP0001819_abnormal_immune_cell | 2.38306565 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.36487829 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.29978339 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.29268403 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.23044476 |
| 23 | MP0003724_increased_susceptibility_to | 2.17750684 |
| 24 | MP0004947_skin_inflammation | 2.10149037 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.03800400 |
| 26 | MP0004510_myositis | 1.97936195 |
| 27 | MP0002405_respiratory_system_inflammati | 1.93807965 |
| 28 | MP0005174_abnormal_tail_pigmentation | 1.93297352 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.90946033 |
| 30 | MP0002006_tumorigenesis | 1.90061182 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.88511952 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.87634912 |
| 33 | MP0009278_abnormal_bone_marrow | 1.87080060 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.84087453 |
| 35 | MP0002398_abnormal_bone_marrow | 1.80578122 |
| 36 | MP0000716_abnormal_immune_system | 1.79620030 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.79039091 |
| 38 | MP0001853_heart_inflammation | 1.69150680 |
| 39 | MP0005310_abnormal_salivary_gland | 1.66256498 |
| 40 | MP0003448_altered_tumor_morphology | 1.65694597 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.63877881 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.60846257 |
| 43 | MP0008057_abnormal_DNA_replication | 1.58890678 |
| 44 | MP0009764_decreased_sensitivity_to | 1.56604465 |
| 45 | MP0008469_abnormal_protein_level | 1.55333656 |
| 46 | MP0009840_abnormal_foam_cell | 1.53329038 |
| 47 | MP0002429_abnormal_blood_cell | 1.47640141 |
| 48 | MP0000343_altered_response_to | 1.46112593 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.46045831 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.46045831 |
| 51 | MP0002722_abnormal_immune_system | 1.45017369 |
| 52 | MP0000604_amyloidosis | 1.43800240 |
| 53 | MP0002998_abnormal_bone_remodeling | 1.40110555 |
| 54 | MP0010307_abnormal_tumor_latency | 1.36859946 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.34851496 |
| 56 | MP0003075_altered_response_to | 1.33803036 |
| 57 | MP0003045_fibrosis | 1.33572458 |
| 58 | MP0002163_abnormal_gland_morphology | 1.33415717 |
| 59 | MP0001873_stomach_inflammation | 1.30915733 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.30714085 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.28126701 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.27909656 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 1.24942867 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 1.24297349 |
| 65 | MP0000858_altered_metastatic_potential | 1.23221607 |
| 66 | MP0005166_decreased_susceptibility_to | 1.22931253 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 1.21888681 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 1.18448579 |
| 69 | MP0000372_irregular_coat_pigmentation | 1.18047122 |
| 70 | MP0000371_diluted_coat_color | 1.14220915 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.11017423 |
| 72 | MP0002396_abnormal_hematopoietic_system | 1.10705662 |
| 73 | MP0000490_abnormal_crypts_of | 1.09565918 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.06731248 |
| 75 | MP0002933_joint_inflammation | 1.04737489 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.01541137 |
| 77 | MP0003866_abnormal_defecation | 1.00721384 |
| 78 | MP0005451_abnormal_body_composition | 1.00719347 |
| 79 | MP0001348_abnormal_lacrimal_gland | 1.00572408 |
| 80 | MP0003646_muscle_fatigue | 0.96624499 |
| 81 | MP0008260_abnormal_autophagy | 0.95973961 |
| 82 | MP0003195_calcinosis | 0.95961323 |
| 83 | MP0005379_endocrine/exocrine_gland_phen | 0.93918395 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.92058705 |
| 85 | MP0003828_pulmonary_edema | 0.89710828 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.89172804 |
| 87 | MP0009763_increased_sensitivity_to | 0.89165231 |
| 88 | MP0000703_abnormal_thymus_morphology | 0.88745676 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.83931957 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.83621885 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.83454467 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.83081567 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.82865413 |
| 94 | MP0005257_abnormal_intraocular_pressure | 0.82602297 |
| 95 | MP0003186_abnormal_redox_activity | 0.80446841 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.80253145 |
| 97 | MP0005390_skeleton_phenotype | 0.76585534 |
| 98 | MP0002254_reproductive_system_inflammat | 0.75358369 |
| 99 | MP0000249_abnormal_blood_vessel | 0.73480681 |
| 100 | MP0001663_abnormal_digestive_system | 0.72324071 |
| 101 | MP0005164_abnormal_response_to | 0.71780503 |
| 102 | MP0003795_abnormal_bone_structure | 0.70844220 |
| 103 | MP0003690_abnormal_glial_cell | 0.70756510 |
| 104 | MP0003091_abnormal_cell_migration | 0.69436421 |
| 105 | MP0001851_eye_inflammation | 0.68696565 |
| 106 | MP0005023_abnormal_wound_healing | 0.68305847 |
| 107 | MP0004381_abnormal_hair_follicle | 0.67391233 |
| 108 | MP0002095_abnormal_skin_pigmentation | 0.66539682 |
| 109 | MP0002009_preneoplasia | 0.66347898 |
| 110 | MP0003453_abnormal_keratinocyte_physiol | 0.66247214 |
| 111 | MP0005266_abnormal_metabolism | 0.66040404 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.65998714 |
| 113 | MP0010094_abnormal_chromosome_stability | 0.62109957 |
| 114 | MP0001958_emphysema | 0.60966502 |
| 115 | MP0001919_abnormal_reproductive_system | 0.60174195 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.59571221 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.57260958 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.57117502 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.56890577 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.54704404 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.53695566 |
| 122 | MP0002837_dystrophic_cardiac_calcinosis | 0.48175379 |
| 123 | MP0005647_abnormal_sex_gland | 0.47962124 |
| 124 | MP0008874_decreased_physiological_sensi | 0.47361585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.85925256 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.17377247 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.03575997 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.02742504 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 4.91664196 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.81695847 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.70957006 |
| 8 | Stomatitis (HP:0010280) | 4.70541012 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42890178 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 4.25597993 |
| 11 | Myositis (HP:0100614) | 4.21922055 |
| 12 | Recurrent skin infections (HP:0001581) | 3.97064809 |
| 13 | Orchitis (HP:0100796) | 3.94414554 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 3.94077018 |
| 15 | IgG deficiency (HP:0004315) | 3.91631081 |
| 16 | Recurrent viral infections (HP:0004429) | 3.89365201 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.89068265 |
| 18 | Optic neuritis (HP:0100653) | 3.89068265 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.86857466 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.83853721 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.81990325 |
| 22 | Gingivitis (HP:0000230) | 3.80335302 |
| 23 | Chronic diarrhea (HP:0002028) | 3.66808887 |
| 24 | Encephalitis (HP:0002383) | 3.53119647 |
| 25 | Cellulitis (HP:0100658) | 3.48370523 |
| 26 | Obstructive lung disease (HP:0006536) | 3.46944534 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.46944534 |
| 28 | Prostate neoplasm (HP:0100787) | 3.41655387 |
| 29 | Recurrent sinusitis (HP:0011108) | 3.39363170 |
| 30 | Vasculitis (HP:0002633) | 3.38440589 |
| 31 | Abnormality of B cell number (HP:0010975) | 3.37151996 |
| 32 | B lymphocytopenia (HP:0010976) | 3.34311923 |
| 33 | Chronic otitis media (HP:0000389) | 3.22164667 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 3.13107234 |
| 35 | Gastrointestinal stroma tumor (HP:0100723) | 3.06529744 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.00780347 |
| 37 | Pustule (HP:0200039) | 2.97167230 |
| 38 | Meningitis (HP:0001287) | 2.96877773 |
| 39 | Osteomyelitis (HP:0002754) | 2.95691157 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.89378410 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.89378410 |
| 42 | Gangrene (HP:0100758) | 2.85347637 |
| 43 | Periodontitis (HP:0000704) | 2.84434200 |
| 44 | Gastrointestinal infarctions (HP:0005244) | 2.83141752 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78905923 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78905923 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78905923 |
| 48 | Urticaria (HP:0001025) | 2.78829660 |
| 49 | Abnormality of the pleura (HP:0002103) | 2.76666472 |
| 50 | Hematochezia (HP:0002573) | 2.76318035 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.75483976 |
| 52 | Axonal loss (HP:0003447) | 2.74593314 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.73813986 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.72838853 |
| 55 | Recurrent pneumonia (HP:0006532) | 2.72354854 |
| 56 | Disinhibition (HP:0000734) | 2.69709541 |
| 57 | Colitis (HP:0002583) | 2.61871157 |
| 58 | Arterial thrombosis (HP:0004420) | 2.59043843 |
| 59 | Thick nail (HP:0001805) | 2.58298957 |
| 60 | Recurrent bronchitis (HP:0002837) | 2.58060340 |
| 61 | Lymphoma (HP:0002665) | 2.56141226 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.51918591 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51918591 |
| 64 | Tetraparesis (HP:0002273) | 2.51229370 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.50646500 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.49121204 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48808604 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.48139646 |
| 69 | T lymphocytopenia (HP:0005403) | 2.46551382 |
| 70 | Premature loss of primary teeth (HP:0006323) | 2.46197523 |
| 71 | Gingival bleeding (HP:0000225) | 2.45266383 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44787498 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44787498 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44787498 |
| 75 | IgM deficiency (HP:0002850) | 2.44222601 |
| 76 | Leukocytosis (HP:0001974) | 2.44143130 |
| 77 | Agammaglobulinemia (HP:0004432) | 2.43807321 |
| 78 | Combined immunodeficiency (HP:0005387) | 2.42182135 |
| 79 | Inflammation of the large intestine (HP:0002037) | 2.41328675 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.37627318 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 2.35404337 |
| 82 | Neoplasm of head and neck (HP:0012288) | 2.35098101 |
| 83 | Esophageal neoplasm (HP:0100751) | 2.35098101 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33002014 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.32282392 |
| 86 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31456650 |
| 87 | Leukopenia (HP:0001882) | 2.30980478 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.29502561 |
| 89 | Chest pain (HP:0100749) | 2.27496556 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.24972478 |
| 91 | Joint swelling (HP:0001386) | 2.24547876 |
| 92 | Thyroiditis (HP:0100646) | 2.24539371 |
| 93 | Hemoptysis (HP:0002105) | 2.24474079 |
| 94 | Eosinophilia (HP:0001880) | 2.24148170 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.22274443 |
| 96 | Polyneuropathy (HP:0001271) | 2.21835355 |
| 97 | Nasal polyposis (HP:0100582) | 2.20125796 |
| 98 | Emphysema (HP:0002097) | 2.18488650 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.18110431 |
| 100 | Thrombocytosis (HP:0001894) | 2.16153463 |
| 101 | Restrictive lung disease (HP:0002091) | 2.15800149 |
| 102 | Petechiae (HP:0000967) | 2.14865222 |
| 103 | Myocardial infarction (HP:0001658) | 2.14233679 |
| 104 | Loss of speech (HP:0002371) | 2.14131457 |
| 105 | Anorexia (HP:0002039) | 2.13740433 |
| 106 | Lymphopenia (HP:0001888) | 2.13545303 |
| 107 | Bronchitis (HP:0012387) | 2.12677655 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.12288889 |
| 109 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11384188 |
| 110 | Osteolytic defects of the hand bones (HP:0009699) | 2.11384188 |
| 111 | Granulocytopenia (HP:0001913) | 2.10760240 |
| 112 | Amaurosis fugax (HP:0100576) | 2.09029395 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07587976 |
| 114 | Epistaxis (HP:0000421) | 2.06225901 |
| 115 | Sepsis (HP:0100806) | 2.06076620 |
| 116 | Abnormality of T cells (HP:0002843) | 2.06001377 |
| 117 | Vertebral compression fractures (HP:0002953) | 2.05859005 |
| 118 | Agnosia (HP:0010524) | 2.03759225 |
| 119 | IgA deficiency (HP:0002720) | 2.03671248 |
| 120 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03263746 |
| 121 | Bone pain (HP:0002653) | 2.01549289 |
| 122 | Acute hepatic failure (HP:0006554) | 2.01087955 |
| 123 | Increased IgE level (HP:0003212) | 1.99070247 |
| 124 | Increased IgM level (HP:0003496) | 1.98599537 |
| 125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98442406 |
| 126 | Skin rash (HP:0000988) | 1.97938680 |
| 127 | Fatigue (HP:0012378) | 1.96917678 |
| 128 | Abnormality of the nasal mucosa (HP:0000433) | 1.95436484 |
| 129 | Pulmonary embolism (HP:0002204) | 1.95427355 |
| 130 | Arthralgia (HP:0002829) | 1.95263113 |
| 131 | Glomerulonephritis (HP:0000099) | 1.93819574 |
| 132 | Keratitis (HP:0000491) | 1.93169140 |
| 133 | Parakeratosis (HP:0001036) | 1.91183632 |
| 134 | Pulmonary fibrosis (HP:0002206) | 1.91067929 |
| 135 | Abnormality of male internal genitalia (HP:0000022) | 1.86025634 |
| 136 | Neutropenia (HP:0001875) | 1.84638118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.46435773 |
| 2 | MAP3K14 | 3.98267619 |
| 3 | MAP4K1 | 3.54147609 |
| 4 | TBK1 | 3.52894763 |
| 5 | TYK2 | 3.15286741 |
| 6 | BLK | 3.04363629 |
| 7 | KIT | 2.97077049 |
| 8 | IRAK3 | 2.88739159 |
| 9 | IKBKE | 2.74914835 |
| 10 | JAK3 | 2.64623022 |
| 11 | ERN1 | 2.63348787 |
| 12 | IRAK4 | 2.47814062 |
| 13 | EIF2AK3 | 2.37786747 |
| 14 | TXK | 2.31791523 |
| 15 | PBK | 2.26785076 |
| 16 | IKBKB | 2.21953904 |
| 17 | MAP3K13 | 2.01543417 |
| 18 | JAK1 | 2.01075563 |
| 19 | FRK | 1.96181649 |
| 20 | GRK7 | 1.92697356 |
| 21 | MST4 | 1.86491670 |
| 22 | NME2 | 1.83003875 |
| 23 | ADRBK2 | 1.82178278 |
| 24 | TAOK3 | 1.80360529 |
| 25 | CSF1R | 1.67417767 |
| 26 | SYK | 1.67316752 |
| 27 | MATK | 1.64785150 |
| 28 | BTK | 1.62076791 |
| 29 | ZAP70 | 1.58457341 |
| 30 | PRPF4B | 1.50924858 |
| 31 | HCK | 1.40144860 |
| 32 | TLK1 | 1.36979955 |
| 33 | LCK | 1.36238311 |
| 34 | CSK | 1.36208817 |
| 35 | LYN | 1.34943888 |
| 36 | MAP3K10 | 1.34593570 |
| 37 | CHUK | 1.34244437 |
| 38 | IRAK1 | 1.23745952 |
| 39 | STK10 | 1.19717903 |
| 40 | TEC | 1.19254968 |
| 41 | FES | 1.13362468 |
| 42 | MAP2K3 | 1.12719803 |
| 43 | RPS6KA4 | 1.06744057 |
| 44 | PIM1 | 1.04036184 |
| 45 | CLK1 | 0.99703160 |
| 46 | ACVR1B | 0.99390896 |
| 47 | SIK3 | 0.98762361 |
| 48 | SCYL2 | 0.97870130 |
| 49 | FGR | 0.96362558 |
| 50 | JAK2 | 0.93157360 |
| 51 | MST1R | 0.88908133 |
| 52 | STK4 | 0.88578526 |
| 53 | MAPK11 | 0.87793255 |
| 54 | CDC42BPA | 0.86828677 |
| 55 | ITK | 0.83932279 |
| 56 | NEK9 | 0.81421071 |
| 57 | DDR2 | 0.80471223 |
| 58 | MAP3K11 | 0.80183295 |
| 59 | LRRK2 | 0.79927556 |
| 60 | GRK6 | 0.79186747 |
| 61 | STK24 | 0.78711081 |
| 62 | TGFBR2 | 0.77362505 |
| 63 | EPHB1 | 0.76145189 |
| 64 | PIM2 | 0.75998424 |
| 65 | YES1 | 0.75790893 |
| 66 | MARK3 | 0.74692675 |
| 67 | FGFR3 | 0.74541777 |
| 68 | BMX | 0.73772945 |
| 69 | CDK12 | 0.72700695 |
| 70 | DAPK2 | 0.69802392 |
| 71 | PTK6 | 0.67230510 |
| 72 | TAOK2 | 0.64938081 |
| 73 | EGFR | 0.64884090 |
| 74 | TTN | 0.63287831 |
| 75 | MAP2K6 | 0.62606341 |
| 76 | TNK2 | 0.60676843 |
| 77 | ABL1 | 0.60359194 |
| 78 | PRKCD | 0.56810251 |
| 79 | TRPM7 | 0.55557119 |
| 80 | SIK2 | 0.55438715 |
| 81 | MAP3K5 | 0.54129649 |
| 82 | NLK | 0.50970693 |
| 83 | RPS6KA5 | 0.49968456 |
| 84 | PIK3CG | 0.49647343 |
| 85 | MAP3K3 | 0.49312221 |
| 86 | FGFR4 | 0.49150413 |
| 87 | ABL2 | 0.47519378 |
| 88 | BRD4 | 0.46315367 |
| 89 | PKN1 | 0.46140056 |
| 90 | CAMK1D | 0.45920246 |
| 91 | PASK | 0.45220438 |
| 92 | DAPK3 | 0.44970742 |
| 93 | ZAK | 0.44846831 |
| 94 | EIF2AK2 | 0.43184938 |
| 95 | CAMKK2 | 0.42669924 |
| 96 | RPS6KA6 | 0.42141927 |
| 97 | RIPK1 | 0.41311298 |
| 98 | FYN | 0.40221595 |
| 99 | PDK1 | 0.39525393 |
| 100 | PRKG2 | 0.39431170 |
| 101 | PDGFRB | 0.39138145 |
| 102 | CCNB1 | 0.38605252 |
| 103 | CDK4 | 0.37664426 |
| 104 | EEF2K | 0.36405004 |
| 105 | PRKCQ | 0.36185383 |
| 106 | BUB1 | 0.34810134 |
| 107 | OXSR1 | 0.34479496 |
| 108 | NUAK1 | 0.32201248 |
| 109 | MAP3K1 | 0.31736475 |
| 110 | MAPK4 | 0.31276932 |
| 111 | MAP4K2 | 0.30746668 |
| 112 | FLT3 | 0.30725851 |
| 113 | TAOK1 | 0.30186921 |
| 114 | MOS | 0.29876880 |
| 115 | CDK19 | 0.29818535 |
| 116 | IRAK2 | 0.29791883 |
| 117 | STK3 | 0.29763656 |
| 118 | RPS6KC1 | 0.29738450 |
| 119 | RPS6KL1 | 0.29738450 |
| 120 | MAPKAPK2 | 0.28243451 |
| 121 | ALK | 0.27969077 |
| 122 | PKN2 | 0.27869374 |
| 123 | CDK6 | 0.27371489 |
| 124 | KDR | 0.25876094 |
| 125 | PDPK1 | 0.25831442 |
| 126 | MAP3K12 | 0.24579038 |
| 127 | BMPR2 | 0.23966386 |
| 128 | INSR | 0.22688572 |
| 129 | IGF1R | 0.21960948 |
| 130 | MELK | 0.21762810 |
| 131 | TYRO3 | 0.21571651 |
| 132 | TRIB3 | 0.21219991 |
| 133 | MAP3K8 | 0.20521800 |
| 134 | EPHA3 | 0.20514967 |
| 135 | HIPK2 | 0.20120543 |
| 136 | VRK1 | 0.17821244 |
| 137 | ATR | 0.17511705 |
| 138 | NME1 | 0.17221174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.26787944 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.92746016 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.83265588 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.68867642 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.55587628 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.42694470 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.36378376 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27849504 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.22765110 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.19590980 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.17309446 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16561116 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.10150501 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09439905 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.04760581 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.03734559 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.94126821 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.93828599 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91686022 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.88989616 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.88472067 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.86096815 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84855157 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.84356758 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80518819 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.72413506 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71227255 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66164185 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64102192 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.56585832 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53861831 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.53058291 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.47422829 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45991022 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.44040352 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42305959 |
| 37 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33452521 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.27481812 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.24871245 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.24454747 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22915907 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22054307 |
| 43 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21504060 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20868661 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20855670 |
| 46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17252024 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14866263 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98166752 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97419451 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95246278 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93712896 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92197504 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90246355 |
| 54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88654270 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84490572 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80342454 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80075650 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77349125 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75133887 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.74721422 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73103396 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.72625010 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71782489 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69654262 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69438890 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.68600581 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63250571 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61353963 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59716975 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59395155 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59072545 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57939244 |
| 73 | Homologous recombination_Homo sapiens_hsa03440 | 0.57158740 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55731409 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50930237 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50529851 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.48172144 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47180891 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46733133 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44582579 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.43224935 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42799385 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.42778271 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41351211 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39567722 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37975878 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37266070 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37008900 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36411547 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.29057342 |
| 91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27900593 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26779091 |
| 93 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.26722361 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26707899 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26222151 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23618639 |
| 97 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.23474831 |
| 98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.23348558 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23336373 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23048469 |
| 101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22995593 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22752587 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.22748184 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21727210 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21536280 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20666480 |
| 107 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.20178443 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.19923622 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.19836250 |
| 110 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.18311628 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.17395112 |
| 112 | RNA polymerase_Homo sapiens_hsa03020 | 0.15246952 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10267874 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.08331868 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07948497 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07379783 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05305097 |
| 118 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.04945140 |
| 119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04944884 |
| 120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00685843 |
| 121 | DNA replication_Homo sapiens_hsa03030 | -0.0660159 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0622093 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0514893 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | -0.0141576 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | -0.0139186 |
| 126 | Protein export_Homo sapiens_hsa03060 | -0.0009096 |

